Carbon nanotubes prolong the regulatory action of nerve growth factor on the endocannabinoid signaling

Physiology and Pharmacology

Volumn 19, Issue 3, 2015, Pages 168-176

  Hassanzadeh, Parichehr ^a,b   Arbabi, Elham ^c   Rostami, Fatemeh ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Carbon nanotubes; Endocannabinoid signaling; Nerve growth factor

Indexed keywords

2 ARACHIDONOYL GLYCEROL; CARBON NANOTUBE; CARBON NANOTUBE NERVE GROWTH FACTOR COMPLEX; CARBOXYL MULTI WALLED CARBON NANOTUBE; ENDOCANNABINOID; ETHYLENEDIAMINE CARBON NANOTUBE; ETHYLENEDIAMINE CARBON NANOTUBE NERVE GROWTH FACTOR COMPLEX; MULTI WALLED NANOTUBE; NERVE GROWTH FACTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; RAT; SCANNING ELECTRON MICROSCOPY; SYNTHESIS;

EID: 84951285809     PISSN: 17350581     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Al-Jamal KT, Gherardini L, Bardi G, Nunes A, Guo C, Bussy C, et al. Functional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencing. Proc Natl Acad Sci USA 2011; 108: 10952-97.
2. Bhirde AA, Patel V, Gavard J, Zhang GF, Sousa AA, Masedunskas A, et al. Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery. Acs Nano 2009; 3: 307-16.
3. Bisogno T, Sepe N, Melck D, Maurelli S, De Petrocellis L, Di Marzo V. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoyl-glycerol in mouse neuroblastoma cells. Biochem J 1997; 322: 671-77.
4. Boyd JG, Gordon T. Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol Neurobiol 2003; 27: 277-324.
5. Calatozzolo C, Salmaggi A, Pollo B, Sciacca FL, Lorenzetti M, Franzini A, Boiardi A, Broggi G, Marras C. Expression of cannabinoid receptors and neurotrophins in human gliomas. Neurol Sci 2007; 28: 304-10.
6. Cellot G, Toma FM, Varley ZK, Laishram J, Villari A, Quintana M, et al. Carbon nanotube scaffolds tune synaptic strength in cultured neural circuits: novel frontiers in nanomaterial-tissue interactions. J Neurosci 2011; 31: 12945-53.
7. Centonze D, Rossi S, Finazzi-Agrò A, Bernardi G, Maccarrone M. The endocannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis. Int Rev Neurobiol 2007; 82: 171-86.
8. Chen W, Xiong Q, Ren Q, Guo Y, Li G. Can amino-functionalized carbon nanotubes carry functional nerve growth factor? Neural Reg Res 2014; 9: 285-92.
9. Cottrell GW. New life for neural networks. Science 2006; 313: 454-55.
10. Cho Y, Borgens RB. Electrically controlled release of the nerve growth factor from a collagen-carbon nanotube composite for supporting neuronal growth. J Mater Chem 2013; 1: 4166-4170.
11. Devane WA, Hanus L, Bruer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258: 1946-49.
12. Fabbro A, Bosi S, Ballerini L, Prato M. Carbon nanotubes: artificial nanomaterials to engineer single neurons and neuronal networks. ACS Chem Neurosci 2012; 3: 611-18.
13. Freitas TA, Mattos AB, Silva BVM, Dutra RF. Amino-functionalization of carbon nanotubes by using a factorial design: human cardiac troponin T immunosensing application. BioMed Res Int 2014 (2014) 929786 (9pp). Gallily R, Breuer A, Mechoulam R. 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor α production in murine macrophages, and in mice. Eur J Pharmacol 2000; 406: 5-7.
14. Hamdi H, De La Torre-Roche R, Hawthorne J, White JC. Impact of non-functionalized and amino-functionalized multiwall carbon nanotubes on pesticide uptake by lettuce (Lactuca sativa L.). Nanotoxicology 2015; 9: 172-180.
15. Hassanzadeh P, Rahimpour S. The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs. Psychopharmacology 2011; 215: 129-41.
16. Hassanzadeh P, Hassanzadeh A. Involvement of the neurotrophin and cannabinoid systems in the mechanisms of action of neurokinin receptor antagonists. Eur Neuropsychopharmcol 2011; 21: 905-17.
17. Hassanzadeh P, Hassanzadeh A. Implication of NGF and endocannabinoid signaling in the mechanism of action of sesamol: a multi-target natural compound with therapeutic potential. Psychopharmacology 2013; 229: 571-78.
18. Hassanzadeh P, Hassanzadeh A. The CB1 Receptor-Mediated Endocannabinoid Signaling and NGF: The Novel Targets of Curcumin. Neurochem Res 2012; 37: 1112-20.
19. Hassanzadeh P, Hassanzadeh A. Effects of different psychotropic agents on the central nerve growth factor protein. Iran J Basic Med Sci 2010; 13: 202-9.
20. Hefti F, Will B. Nerve growth factor is a neurotrophic factor for forebrain cholinergic neurons; implications for Alzheimer's disease. J Neural Transm Suppl 1987; 24: 309-15.
21. Huang F, Wang J, Chen A. Effects of co-grafts mesenchymal stem cells and nerve growth factor suspension in the repair of spinal cord injury. J Huazhong Univ Sci Technolog Med Sci 2006; 26: 206-10.
22. Keimpema E, Barabas K, Morozov YM, Tortoriello G, Torii M, Cameron G, et al. Differential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal path finding. J Neurosci 2010; 30: 13992-14007.
23. Lad SP, Neet KE, Mufson EJ. Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease. Curr Drug Targets CNS Neurol Disord 2003; 2: 315-34.
24. Lee HJ, Park J, Yoon OJ, Kim HW, Lee do Y, Kim do H, et al. Amine-modified single-walled carbon nanotubes protect neurons from injury in a rat stroke model. Nat Nanotechnol 2011; 6: 121-5.
25. Lindsay RM. Neurotrophic growth factors and neurodegenerative diseases: therapeutic potential of the neurotrophins and ciliary neurotrophic factor. Neurobiol Aging 1994; 15: 249-51.
26. Matsumoto K, Sato C, Naka Y, Kitazawa A, Whitby RLD, Shimizu N. Neurite outgrowths of neurons with neurotrophin-coated carbon nanotubes. J Biosci Bioeng 2007; 103: 216-20.
27. Matsumoto K, Sato C, Naka Y, Whitby R, Shimizu N. Stimulation of neuronal neurite outgrowth using functionalized carbon nanotubes. Nanotechnology 2010; 21: 115101.
28. Meng L, Chen R, Jiang A, Wang L, Wang P, Li C, Bai R, et al. Short multiwall carbon nanotubes promote neuronal differentiation of PC12 cells via up-regulation of the neurotrophin signaling pathway. Small 2013; 9: 1786-98.
29. Mohammadi A, Moghaddam AB, Dinarvand R, Rezaei-Zarchi S. Direct electron transfer of polyphenol oxidase on carbon nanotube surfaces: Application in Biosensing. Int J Electrochem Sci 2009; 4: 895-905.
30. Panikashvili D, Simeonidou C, Ben-Shabat S, HanusÏ L, Breuer A, Mechoulam R, et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 2001; 413: 527-31.
31. Patel S, Rademacher DJ, Hillard CJ. Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity. J Pharmacol Exp Ther 2003; 306: 880-88.
32. Paxinos G, Watson C.The rat brain in stereotaxic coordinates. San Diego: Academic press; 2007.
33. Pfister LA, Papaloïzos M, Merkle HP, Gander B. Nerve conduits and growth factor delivery in peripheral nerve repair. J Peripher Nerv Syst 2007; 12: 65-82.
34. Roman JA, Niedzielko TL, Haddon RC, Parpura V, Floy CL. Single walled carbon nanotubes chemically functionalized with polyethylene glycol promote tissue repair in a rat model of spinal cord injury. J Neurotrauma 2011; 28: 2349-62.
35. Sinor AD, Irvin SM, Greenberg DA. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci Lett 2000; 278: 157-60.
36. Son SJ, Bai X, Nan A, Ghandehari H, Lee SB, Template synthesis of multifunctional nanotubes for controlled release. J Control Release 114 (2006) 143-52.
37. Stella N, Schweitzer P, Piomelli D. A second endogenous cannabinoid that modulates long-term potentiation. Nature (Lond) 1997; 388: 773-78.
38. van der Stelt M, Di Marzo V. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders. Eur J Pharmacol 2003; 480: 133-50.
39. Ya-Ping S, Kefu F, Yi L, Weijie H. Functionalized carbon nanotubes: properties and applications. Acc Chem Res 2002; 35: 1096-1104.
40. Yen SJ, Hsu WL, Chen YC, Su HC, Chang YC, Chen H, et al. The enhancement of neural growth by amino-functionalization on carbon nanotubes as a neural electrode. Biosens Bioelectron 2011; 26: 4124-32.
41. Yoshida T, Fukaya M, Uchigashima M, Miura E, Kamiya H, Kano M, et al. Localization of diacylglycerol lipase around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidinoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J Neurosci 2006; 26: 4740-51.
42. Zhang S, Uludağ H. Nanoparticulate Systems for Growth Factor Delivery. Pharm Res 2009; 26: 1561-80.
43. Zhao DC, Alizadeh D, Zhang LY, Liu W, Farrukh O, Manuel E, et al. Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity. Clin Cancer Res 2011; 17: 771-82.